Gregory is a biotech leader with over 25 years of experience, currently serving as the Head of Research and Technology at Sangamo Therapeutics. He has been instrumental in the development and commercialization of three major genome editing technologies: ZFNs, CRISPR, and RNA-guided retrotransposons. He holds a Ph.D. from the University of Oklahoma.
Outside of his direct research, Gregory shows a deep appreciation for the people who have shaped his career. He has publicly expressed immense gratitude for his Ph.D. advisor, highlighting the importance of mentorship in science and staying connected to foundational scientific principles.
He played a key role in launching the worlds first commercial genome editing tools for human somatic cell research.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.